Gaboxadol also known as 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol (THIP) is an experimental sleep aid drug developed by Lundbeck and Merck, who reported increased deep sleep without the reinforcing effects of benzodiazepines. Development of Gaboxadol was stopped in March 2007 after concerns regarding safety and efficacy. It acts on the GABA system, but in a seemingly different way from benzodiazepines and other sedatives. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Gabodux and Gaboxadolum. Its PubChem CID is 3448.
Gaboxadol
| CAS No | 64603-91-4 |
|---|---|
| Molecular Formula | C6H8N2O2 |
| Molecular Weight | 140.14 g/mol |
| Synonyms | 4,5,6,7-tetrahydro-[1,2]oxazolo[5,4-c]pyridin-3-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Gaboxadol also known as 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol (THIP) is an experimental sleep aid drug developed by Lundbeck and Merck, who reported increased deep sleep without the reinforcing effects of benzodiazepines.
The listed CAS number is 64603-91-4.
The listed molecular formula is C6H8N2O2.
The listed molecular weight is 140.14 g/mol.
4,5,6,7-tetrahydro-[1,2]oxazolo[5,4-c]pyridin-3-one.
The source lists Gabodux and Gaboxadolum.